Literature DB >> 9811389

Membranous glomerulonephritis and nephrosis post factor IX infusions in hemophilia B.

V R Dharnidharka1, C Takemoto, B M Ewenstein, S Rosen, H W Harris.   

Abstract

Children with hemophilia B who receive exogenous factor IX infusions may rarely develop inhibitors to the exogenous factor IX and require desensitization. Nephrotic syndrome has recently been described in some of these children. We report the renal clinicopathological findings in a child with severe factor IX deficiency, requiring induction of an immune tolerance protocol, who developed nephrotic syndrome. Renal biopsy revealed peripheral capillary wall thickening and a spike appearance consistent with membranous glomerulonephritis. Electron microscopy showed prominent deposits throughout the thickness of the basement membrane. Factor IX dose reduction was accompanied by reversal of the child's nephrotic syndrome without relapses.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811389     DOI: 10.1007/s004670050522

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  4 in total

1.  Successful management of factor IX inhibitor-associated nephrotic syndrome in a hemophilia B patient.

Authors:  Priya Verghese; Stephen Darrow; Margaret H Kurth; Robyn C Reed; Youngki Kim; Susan Kearney
Journal:  Pediatr Nephrol       Date:  2013-02-06       Impact factor: 3.714

Review 2.  Desensitization and immune tolerance induction in children with severe factor IX deficiency; inhibitors and adverse reactions to replacement therapy: a case-report and literature review.

Authors:  Andrea Bon; Massimo Morfini; Alessandro Dini; Francesca Mori; Simona Barni; Sottilotta Gianluca; Maurizio de Martino; Elio Novembre
Journal:  Ital J Pediatr       Date:  2015-02-19       Impact factor: 2.638

Review 3.  Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications.

Authors:  Anshu Kuriakose; Narendra Chirmule; Pradip Nair
Journal:  J Immunol Res       Date:  2016-06-29       Impact factor: 4.818

4.  Primary membranous glomerulonephritis with negative serum PLA2R in haemophilia A successfully managed with rituximab - case report and review of the literature.

Authors:  Nicholas Meyer; Wendy Cooper; Paul Kirwan; Roger Garsia; Scott Dunkley; David M Gracey
Journal:  BMC Nephrol       Date:  2021-07-22       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.